Merkle Science Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
55
- Latest Deal Type
-
Later Stage VC
- Investors
-
42
Merkle Science General Information
Description
Operator of a risk monitoring platform intended to detect and prevent the illegal use of cryptocurrency. The company's platform is an easy-to-use rule management interface that helps users visualize account activity across time and generate forensic reports, enabling blockchain companies, crypto-exchanges, investment funds, banks, and regulators to perform due diligence and compliance on the blockchain to detect, investigate, and prevent cryptocurrency fraud.
Contact Information
Website
www.merklescience.comCorporate Office
- 134 North 4th Street
- Brooklyn
- New York, NY 11249
- United States
Corporate Office
- 134 North 4th Street
- Brooklyn
- New York, NY 11249
- United States
Merkle Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 01-Jul-2026 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 10. Accelerator/Incubator | 16-Mar-2023 | Completed | Generating Revenue | |||
| 9. Early Stage VC (Series A) | 05-Aug-2022 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 22-Jun-2022 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series A1) | 28-Sep-2021 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 27-Jun-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 04-May-2020 | $867K | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Jan-2020 | $867K | Completed | Generating Revenue |
Merkle Science Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Seed | 37,488 | $28.53 | $28.53 | 1x | $28.53 | 17.62% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Merkle Science Comparisons
Industry
Financing
Details
Merkle Science Competitors (4)
One of Merkle Science’s 4 competitors is Chainalysis, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chainalysis | Venture Capital-Backed | New York, NY | ||||
| Elliptic | Venture Capital-Backed | London, United Kingdom | ||||
| Xapo Bank | Venture Capital-Backed | Gibraltar, Gibraltar | ||||
| BitPay | Venture Capital-Backed | Atlanta, GA |
Merkle Science Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Merkle Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Merkle Science Investors (42)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SNZ Holding | Venture Capital | Minority | ||
| Village Capital | Accelerator/Incubator | |||
| 500 Global | Accelerator/Incubator | Minority | ||
| 500 Southeast Asia | Corporate Venture Capital | Minority | ||
| Aeon Strategies | Venture Capital | Minority |
Merkle Science Acquisitions (1)
Merkle Science’s most recent deal was a Merger/Acquisition with Staging Labs. The deal was made on 04-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Staging Labs | 04-Jun-2024 | Merger/Acquisition | Network Management Software |
Merkle Science Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Staging Labs | Miami, FL | 2022 |
Merkle Science FAQs
-
When was Merkle Science founded?
Merkle Science was founded in 2018.
-
Where is Merkle Science headquartered?
Merkle Science is headquartered in New York, NY.
-
What is the size of Merkle Science?
Merkle Science has 55 total employees.
-
What industry is Merkle Science in?
Merkle Science’s primary industry is Financial Software.
-
Is Merkle Science a private or public company?
Merkle Science is a Private company.
-
What is Merkle Science’s current revenue?
The current revenue for Merkle Science is .
-
How much funding has Merkle Science raised over time?
Merkle Science has raised $27.5M.
-
Who are Merkle Science’s investors?
SNZ Holding, Village Capital, 500 Global, 500 Southeast Asia, and Aeon Strategies are 5 of 42 investors who have invested in Merkle Science.
-
Who are Merkle Science’s competitors?
Chainalysis, Elliptic, Xapo Bank, and BitPay are competitors of Merkle Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
